• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    8.900 +0.250 (+2.89%)
    Streaming Delayed Price Updated: 3:57 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 10,695
    Open 8.490
    Bid (Size) 8.400 (10)
    Ask (Size) 9.000 (14)
    Prev. Close 8.650
    Today's Range 8.420 - 8.940
    52wk Range 4.930 - 221.94
    Shares Outstanding 574,580
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Rogue Rings of DNA Expose Brain Tumor Secrets
    Via Investor Brand Network
    New Research Suggests Dietary Change Could Improve Glioblastoma Treatment Outcomes
    Via Investor Brand Network

    Performance

    YTD
    -87.3%
    -87.3%
    1 Month
    +45.4%
    +45.4%
    3 Month
    -11.4%
    -11.4%
    6 Month
    -43.8%
    -43.8%
    1 Year
    -89.6%
    -89.6%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    NCI Halts Funding for Consortium Conducting Trials on Childhood Brain Cancers
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    Via ACCESS Newswire
    Study Finds Link Between Head Injuries and Elevated Brain Cancer Risk
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Drug Development and Market Potential on BioMedWire Podcast
    Via Investor Brand Network
    Blocking Glioblastoma-Triggered Brain Damage Could Slow the Aggressive Tumor’s Growth
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial
    Via Investor Brand Network
    CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
    Via ACCESS Newswire
    InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Webull Financial Biotech/MedTech Webinar Series
    Via Investor Brand Network
    What Women Need to Know About Benign Brain Tumors
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
    Via ACCESS Newswire
    Study Reveals Potential Way to Treat Pediatric Gliomas
    Via Investor Brand Network
    Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment
    Via Investor Brand Network
    InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Virtual Investor Summer Spotlight Conference
    Via Investor Brand Network
    Unexpected Finding Potentially Opens the Door to Universal Vaccines Against Cancer
    Via Investor Brand Network
    CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
    Via ACCESS Newswire
    JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
    Via ACCESS Newswire
    New Machine Learning Model Predicts Cancer Severity, Aids Treatment Planning
    Via Investor Brand Network
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Reverse Stock Split
    Via ACCESS Newswire
    New Study Suggests Concussions Could Lead to Higher Risks of Brain Cancer
    Via Investor Brand Network

    Frequently Asked Questions

    Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
    CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
    What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
    The current price of CNS Pharmaceuticals, Inc. - Common Stock is 8.900
    When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 09/26/25 03:57 PM ET
    What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 5.11M
    How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
    CNS Pharmaceuticals, Inc. - Common Stock has 5M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.